drugset / Trial / NCT05251636
Adjunct Episcleral Brachytherapy for PCV
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is investigating the use of episcleral brachytherapy (ESB) adjunct to aflibercept compared to aflibercept monotherapy for the treatment of polyploid choroidal vasculopathy (PCV) in patients experiencing an inadequate response to anti-VEGF monotherapy.
Timeline
- Start
- 2025-03
- Primary completion
- 2026-09
- Completion
- 2028-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Aflibercept | Protein / enzyme biologic | — | Intravitreal |